Home > News > Pro-Pharmaceuticals Reports Second Quarter 2006 Results
August 14th, 2006
Pro-Pharmaceuticals Reports Second Quarter 2006 Results
Abstract:
Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel nanotechnology carbohydrate therapeutic compounds, today reported its financial results for the three and six months ended June 30, 2006. For the second quarter of 2006, the Company reported a net loss of $1,184,000, or $0.04 per share ($0.08 fully diluted), compared with a net loss of $1,698,000, or $0.06 per share (basic & fully diluted), for the same period in 2005.
Source:
businesswire
Bookmark:
| Related News Press |
Announcements
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025
A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||